According to the World Health Organisation, more than 360 million people worldwide suffer from hearing loss. Approximately one third of the population over 65 years old is affected by age-related hearing loss, also known as presbycusis, making it the second most common cause of disability in older people. There is no restorative treatment for deafness but functional replacement by means of prosthesis. Therefore, prevention and treatment of hearing loss is an unmet medical need.
It is essential for Europe future aged population to have well-trained people available to understand hearing loss from a general perspective. According to this, the foreseen secondments and training activities will involve a total of 15 experienced and early-stage researchers.
[Action on Hearing Loss] Read about recent research from the US, which has uncovered a new way to re-grow hair cells in the lab – and which could, one day, help restore lost hearing.
[Action on Hearing Loss] Researchers in Boston have used improved gene therapy to restore hearing in mice – enough to be able to hear a whisper. The mice have a particular type of Usher syndrome, a condition which causes profound hearing loss (alongside vision loss) in those affected. Carina, from the Biomedical Research team of Action on Hearing Loss, has blogged about the findings, and what this might mean for using gene therapy to treat hearing loss in people.
On the edition of March 2017, eLive has published a serie of 4 articles titled “Plain-language summaries of research”.
[hear-it.org] Hearing loss is more common among Canadian youth than previously reported, a study finds.
On 1 March, MEPs Helga Stevens and Roberta Metsola hosted a lunch debate in the European Parliament titled, “Action for hearing loss: Make a sound investment”.
- May 25, 2017 » Bilbao, Spain
- September 10-14 » Jerusalem, Israel
- September 7-10, 2017 » Jerusalem, Israel
- June 12-15, 2017 » Malta
- June 7-10, 2017 » Interlaken, Switzerland
- view all events »